◄ back to all posts

LCI: Lannett Co., Inc. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 367.13
Enterprise Value ($M) 981.67
Book Value ($M) 318.10
Book Value / Share 7.89
Price / Book 1.14
NCAV ($M) -418.76
NCAV / Share -10.38
Price / NCAV -0.86

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -0.17
Return on Equity (ROE) -0.45

Liquidity (mrq)
Quick Ratio 1.60
Current Ratio 2.43

Balance Sheet (mrq) ($M)
Current Assets 435.07
Assets 1,171.93
Liabilities 853.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -262.32
Net Income -272.11
Earnings Per Share Diluted -7.20
Earnings Per Share Basic -7.20

Cash Flow Statement (mra) ($M)
Cash From Operations 176.31
Cash from Investing -7.29
Cash from Financing -7.29

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13G/A D. E. Shaw & Co, L.p. 8.50 1.09
2020-02-11 13G Vanguard Group Inc 5.85 172.86
2020-02-11 13G Lsv Asset Management 5.21 0.32
2020-02-04 13G/A BlackRock Inc. 13.00 9.69
2020-01-24 13G JP Morgan Chase & Co 6.80
2019-09-10 13G/A Mintbroker International, Ltd. 0.00 -100.00
2019-02-12 13G/A Flynn James E 0.00 -100.00
2018-09-11 13G/A Snow Capital Management Lp 0.90 -87.92
2018-02-06 13G/A Invesco Ltd. 2.10 -59.22
2015-12-03 13G Ucb S.a. 6.40

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-02-06 10-Q LCI / Lannett Co., Inc. 10-Q – Quarterly Report – 10-Q
2019-11-07 10-Q LCI / Lannett Co., Inc. 10-Q – Quarterly Report – 10-Q
2019-08-28 10-K LCI / Lannett Co., Inc. 10-K – Annual Report – 10-K
2019-05-07 10-Q LCI / Lannett Co., Inc. 10-Q Quarterly Report 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-02-14 83,846 432,700 19.38
2020-02-13 103,900 524,000 19.83
2020-02-12 99,482 558,600 17.81
2020-02-11 142,853 634,100 22.53
2020-02-10 123,556 627,100 19.70

(click for more detail)

Similar Companies
EBS – Emergent Biosolutions, Inc. HSP – Hospira
JNJ – Johnson & Johnson LLY – Eli Lilly & Co.
MNK – Maillinckrodt plc.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts
401 K